Authors' Comments ::: CNS & Neurological Disorders - Drug Targets

ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)

Volume 16, 10 Issues, 2017

Download PDF Flyer

CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Stephen D. Skaper
Department of Pharmaceutical and Pharmacological Sciences
University of Padova

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.188
5 - Year: 2.599

Authors' Comments

"On behalf of all authors, I wanted to take a few moments to reflect favorably on our experience in having our manuscript "Utilizing Delta Opioid Receptors And Peptides For Cytoprotection: Implications In Stroke And Other Neurological Disorders" published in CNS & Neurological Disorders - Drug Targets. We extend our appreciation for the professionalism, efficient communication, and expeditious pace of publication which we have experienced with your journal, and we look forward to future opportunities to contribute to your respected, high-quality journals."

Cesar V. Borlongan
(Morsani College of Medicine, University of South Florida, United States)

Has contributed: Utilizing Delta Opioid Receptors And Peptides For Cytoprotection: Implications In Stroke And Other Neurological Disorders
"I am extremely grateful for working with Bentham Science. In my opinion, it is one of the best publishers."

Gjumrakch Aliev, MD & PhD
(President "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA)

Has contributed: Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound
"For me it is a honor be part of CNSNDDT. As an editorial board member, my mission is work hard to contribute to CNSNDDT, either as author or as reviewer, allowing the progress of our jornal."

Dr. Sergio Machado
(The Panic and Respiration Laboratory, Institute of Psychiatry (IPUB) – Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)

Has contributed: Comparison Among Aerobic Exercise and Other Types of Interventions to Treat Depression: A Systematic Review
"I have nothing but positive comments for Bentham Science Publishers, as my experience has always been pleasant. I have always received prompt service from Bentham Science."

Dr. Celina S. Liu
(Department of Human Biology, University of Toronto, Toronto, ON, Canada)

Has contributed: Towards a “Metabolic” Subtype of Major Depressive Disorder: Shared Pathophysiological Mechanisms May Contribute to Cognitive Dysfunction
"I have had a great experience working with Bentham Science Publishers! I published my papers not only in CNS, but in other BSP journals as well. Their publishing process is fast and efficient."

Dr. Prof.. Sergio Machado
(Institute of Psychiatry, Federal, Brazil)

Has contributed: High-Frequency rTMS to Treat Refractory Binge Eating Disorder and Comorbid Depression: A Case Report
"I found the handling and reviewing of our manuscripts problem-free; feedback from the referees was both rapid and constructive. Galley proofs were received only a short time after acceptance. I have already received a number of enquiries from the scientific community for a copy. I would definitely recommend CNS & Neurological Disorders - Drug Targets to authors for their future publications."

Dr. Stephen Skaper
(Editor-in-Chief CNS & Neurological Disorders-Drug Targets, )

Has contributed: Astrocyte-Microglia Cooperation in the Expression of a Pro-Inflammatory Phenotype
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017Pain Therapeutics

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science